Skip to content

Clinical trials

Nervous System Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Country / region: Australia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20142
20152
20177
20185
20193
20202
20216
20224
20234
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated9
Recruiting7
Active, not recruiting4
Unknown status3
Not yet recruiting1
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Neuroscience Trials Australia4
GlaxoSmithKline3
PTC Therapeutics3
AstraZeneca2
Inmune Bio, Inc.2
Vertex Pharmaceuticals Incorporated2
Xenon Pharmaceuticals Inc.2
4D Molecular Therapeutics1
Abcuro, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases47
Central Nervous System Diseases25
Brain Diseases23
Neurodegenerative Diseases14
Genetic Diseases, Inborn12
Dementia10
Alzheimer Disease9
Mental Disorders9
Neuromuscular Diseases9
Cardiovascular Diseases8

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.